The Division of Laboratory Medicine is housed within BMC’s Department of Pathology & Laboratory Medicine and is affiliated with the Boston University Chobanian & Avedisian School of Medicine. The division is divided into multiple sections, each with its own medical director and technical supervisor.
Laboratory Medicine is responsible for:
- All clinical laboratory testing throughout BMC
- Assuring appropriate test reliability
- Laboratory information systems
- Oversight for point-of-care testing
- Reference laboratory referrals
- Result reporting
- Specimen collection
Hours of Operation
STAT Testing: 24/7
STAT turnaround time is one hour or less from time of receipt in the laboratory.
Non-Stat Testing
The schedule varies with the complexity and frequency of non-STAT testing. Routine turnaround time is six hours or less from time of receipt in the laboratory.
Contact Us
Laboratory Phone List
- Main Lab, 670 Albany Lab: 617.414.4060
- Main Lab Blood Bank: 617.638.7844
- Menino Blood Bank: 617.414.4141
- Menino Blood Gas Lab: 617.414.4067
- Microbiology: 617.638.7890
The main laboratory has 24/7/365 staffing. Please call 617.414.4054 to contact the laboratory.
- Office hours for the laboratory are 8 a.m. to 5 p.m. During these hours, please call 617.638.7800.
- Administrative leadership is always available on call:
- Phone: 617.638.5795
- Pager: #1027
- Pager: #6650
- The Laboratory Medicine resident is on call at 617.638.5795 or pager #4564.
Fact Sheets for Laboratory EUA Testing
- Fact Sheet for Patients: Boston Medical Center–Center for Regenerative Medicine (BMC-CReM) COVID-19 RT-PCR (Molecular Laboratory Developed Test (LDT) COVID-19 Authorized Test, Version 1.0)
- Fact Sheet for Recipients: SARS-CoV-2 [COVID-19] IgG Assay—Abbott Laboratories, Inc. (June 4, 2020)
- Fact Sheet for Patients: Abbott RealTime SARS-CoV-2 [COVID-19] Assay—Abbott Molecular, Inc. (June 4, 2020)
- Fact Sheet for Patients: BioFire® Respiratory Panel 2.1 (RP2.1)—BioFire Diagnostics, LLC (May 1, 2020)
- Fact Sheet for Patients: Xpert® Xpress SARS-CoV-2 [COVID-19] PCR Assay— Cepheid (March 20, 2020)
- Fact Sheet for Patients: Simplexa™ SARS-CoV-2 [COVID-19] Direct PCR Assay—DiaSorin Molecular, LLC (June 4, 2020)
- Fact Sheet for Recipients: EUROIMMUN Anti–SARS-CoV-2 [COVID-19] ELISA (IgG) Antibody Test (May 4, 2020)
- Fact Sheet for Patients: Genetic Signatures EasyScreen™ SARS-CoV-2 [COVID-19] Assay (December 18, 2020)
- Fact Sheet for Patients: Aptima® SARS-CoV-2 [COVID-19] PCR Assay—Hologic, Inc. (May 14, 2020)
- Fact Sheet for Individuals: QuickVue At-Home OTC COVID-19 Test—Quidel Corporation (October 21, 2021)
- Fact Sheet for Patients: cobas® liat SARS-CoV-2 [COVID-19] & Influenza A/B PCR (POCT) Assay—Roche Molecular Systems, Inc. (September 3, 2020)
- Fact Sheet for Patients: cobas® liat SARS-CoV-2 [COVID-19] PCR (POCT) Nucleic Acid Test—Roche Molecular Systems, Inc. (February 16, 2023)
- Fact Sheet for Patients: cobas® liat SARS-CoV-2 [COVID-19] PCR Assay—Roche Molecular Systems, Inc. (May 13, 2020)